Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients’ FOXP1 and GGT levels
Abstract Objective To investigate the effect of capecitabine on the sensitivity of oxaliplatin and on the level of transcription factor forkhead box P1 (FOXP1) and gamma-glutamyl transpeptidase (GGT) in patients with intermediate and advanced gastric cancer. Methods A total of 152 Patients with adva...
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
BMC
2025-01-01
|
| Ráidu: | BMC Gastroenterology |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12876-025-03624-5 |